Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Olivier T, Tsantoulis P, Prasad V. Eur Urol 2023 Feb 11:S0302-2838(23)02567-8. doi: 10.1016/j.eururo.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Olivier T, Tsantoulis P, Prasad V. Re: Darolutamide and Survival in Metastatic, Hormone-sensitive Prostate Cancer. Eur Urol 2023 Feb 11:S0302-2838(23)02567-8. doi: 10.1016/j.eururo.2023.
PMID: 36781336